GO
Loading...

Takeover Bids

More

  • PARIS, May 23- The French market regulator has extended a deadline for shareholders of Club Mediterranee to decide on a 557 million euro takeover bid while it seeks clarity on the intentions of a new investor in the holidays group.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity Worldwide Investment, ranking 18th, backed the British company's stance.

  • LONDON, May 20- Bankers advising pharmaceuticals companies Pfizer and Britain's AstraZeneca are likely to miss out on $260- 340 million in fees after the U.S. company's final takeover bid was rejected on Monday.

  • *Strategic Holdings raises Club Med stake above 10 pct. *Source says Strategic Holdings opposed Gaillon Invest bid. *Strategic Holdings says does not want control of group.

  • SYDNEY, May 20- Australia's Treasury Wine Estates is betting its Penfolds brand and a cost-cutting new CEO will boost earnings and justify its decision to reject a $2.90 billion takeover offer from private equity giant Kohlberg Kravis Roberts& Co LP.

  • LAVAL, QUEBEC, May 20- Canada's Valeant Pharmaceuticals International said on Tuesday it will not make an all-cash bid for drugmaker Allergan Inc as many had expected last week when the company said it would improve its cash and stock offer for the Botox maker.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity, ranking 18th, backed the British company's stance.

  • May 20- Canada's Valeant Pharmaceuticals International Inc said it will not make an all-cash bid for drugmaker Allergan Inc as many had expected last week when the company said it would improve its cash and stock offer for the Botox maker.

  • Drug flops from 2004 haunt AstraZeneca investors Tuesday, 20 May 2014 | 9:37 AM ET

    *AstraZeneca has had more than fair share of flops in past. LONDON, May 20- AstraZeneca's confidence in its promising new drugs may have seen off Pfizer's $118 billion takeover bid for now, but investors are left contemplating the lessons from 2004, when it was also trumpeting its product pipeline.

  • LONDON, May 20- AstraZeneca shareholder Schroders urged the company to restart takeover talks with Pfizer, adding its voice to criticism of the British drugmaker's rejection of the U.S. firm's 70 billion pound bid. Schroders is AstraZeneca's twelfth-largest shareholder with a 2 percent stake.

  • *Strategic Holdings raises Club Med stake above 10 pct. Source says Strategic Holdings opposed Gaillon Invest bid. Club Med declined to comment, while Gaillon Invest said it was waiting for Strategic Holdings to clarify its intentions.

  • SYDNEY, May 20- Australia's Treasury Wine Estates, the world's second biggest winemaker by sales, said it rejected a A $3.1 billion takeover offer from private equity giant Kohlberg Kravis Roberts& Co LP on the grounds that it was too low.

  • Pfizer's final bid rejected     Monday, 19 May 2014 | 2:17 PM ET

    $117 billion was not enough for AstraZeneca. CNBC's Meg Tirrell looks at Pfizer and AstraZeneca's stocks.

  • Next big takeover     Monday, 19 May 2014 | 2:12 PM ET

    CNBC's Herb Greenberg plays a game of "deal or no deal" and rounds up potential next takeover targets.

  • LONDON, May 19- U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.

  • May 19- Activist investor William Ackman said on Monday that Allergan Inc's chief executive has a "disabling" conflict of interest because accepting a takeover by Valeant Pharmaceuticals International likely means he would lose his job. Ackman and Valeant launched a $47 billion takeover of the company on April 22, but so far Allergan has rejected the advances.

  • *AstraZeneca slumps after rejecting "final" Pfizer bid. LONDON, May 19- European equities slid on Monday, pulled down by pharmaceuticals group AstraZeneca, which slumped after rejecting a Pfizer takeover bid, and by Deutsche Bank, where a capital increase weighed on bank stocks.

  • LONDON, May 19- British pharmaceuticals giant AstraZeneca faces a clash with its shareholders amid mounting disappointment at its rejection on Monday of a sweetened takeover offer by Pfizer.

  • LONDON, May 18- U.S. drugmaker Pfizer Inc is planning to raise its offer for AstraZeneca Plc as it works with its advisers against the clock in a battle where they have just eight days left to move under British takeover rules.

  • Clock ticking for Pfizer to raise AstraZeneca bid Sunday, 18 May 2014 | 8:30 AM ET

    LONDON, May 18- Pfizer is considering raising its offer for AstraZeneca as it works with its advisers against the clock in a battle where they have just eight days left to move under British takeover rules.